Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings-Reference-Cited by-同舟云学术

Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings

Published:2014-01 Issue:1 Volume:22 Page:167-177
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Lee Hyun,Mittal Anuradha,Patel Kavankumar,Gatuz Joseph L.,Truong Lena,Torres Jaime,Mulhearn Debbie C.,Johnson Michael E.

Funder

National Institutes of Health

National Science Foundation

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference64 articles.

1. A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome

2. World Health Organization. 2004. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003. Communicable Disease Surveillance & Response (CSR). http://www.who.int/csr/sars/country/table2004_04_21/en.

3. The Papain-Like Protease of Severe Acute Respiratory Syndrome Coronavirus Has Deubiquitinating Activity

4. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

5. Characterization and Complete Genome Sequence of a Novel Coronavirus, Coronavirus HKU1, from Patients with Pneumonia

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Nirmatrelvir Resistance Mutations in SARS-CoV-2 3CLpro: A Computational-Experimental Approach;Journal of Chemical Information and Modeling;2023-11-10

2. Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review;European Journal of Medicinal Chemistry;2023-11

3. Identification of small molecule inhibitors against MMP-14 via High-Throughput screening;Bioorganic & Medicinal Chemistry;2023-05

4. Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses;European Journal of Medicinal Chemistry;2023-03

5. An Updated and Focused Review on Heterocyclic Inhibitors for SARSCoV and SARS-CoV-2 3CLpro;Mini-Reviews in Medicinal Chemistry;2023-03